The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFederal Bk S Regulatory News (FEDS)

Share Price Information for Federal Bk S (FEDS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.92
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.92
High: 0.00
Low: 0.00
Prev. Close: 0.92
FEDS Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3rd Quarter Results

18 Jan 2016 07:00

RNS Number : 1041M
Federal Bank Ltd (The)
16 January 2016
 



 

SDF-24/ /2015-16 16th January 2016

To,

The London Stock Exchange

 

Dear Sir,

We enclose herewith the UnAudited Financial Results of the Bank alongwith Limited Review Report for the period ended December 31, 2015 which was approved at the Bank's Board of Directors meeting held on 12th January 2016.

 

Kindly take the same on your record.

 

For The Federal Bank Limited

 

Girish Kumar G

COMPANY SECRETARY

 

 

 

 

 

Deloitte

Haskins & Sells

M P Chitale & Co.

Chartered Accountants

Wilmont Park Business Centre

1st Floor, Warriam Road

Kochi - 682 016

INDIA

Chartered AccountantsFirst Floor, Hamam HouseAmbalal Doshi Marg, FortMumbai - 400 001INDIA

Tel: +91-22-22651186Fax:+91-22-22655334 

 

 

INDEPENDENT AUDITORS' REVIEW REPORT ON

REVIEW OF INTERIM FINANCIAL RESULTS

TO THE BOARD OF DIRECTORS OF

THE FEDERAL BANK LIMITED

 

1. We have reviewed the accompanying Statement of Standalone Unaudited Financial Results of THE FEDERAL BANK LIMITED ("the Bank") for the Quarter and Nine Months ended 31st December, 2015 ("the Statement"), excluding the "Pillar 3 disclosures and leverage ratio under Basel III Capital Regulations" disclosed on the Bank's website and in respect of which a link has been provided in the Statement, being submitted by the Bank pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This Statement which is the responsibility of the Bank's Management and approved by the Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Accounting Standard for Interim Financial Reporting (AS 25), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder, guidelines issued by Reserve Bank of India and other accounting principles generally accepted in India. Our responsibility is to issue a report on the Statement based on our review.

 

2. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410'Review of Interim Financial Information Performed by the Independent Auditor of the Entity', issued by the Institute of Chartered Accountants of India. This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarily to inquiries of Bank personnel and analytical procedures applied to financial data and thus provides less assurance than an audit. We have not performed an audit and, accordingly, we do not express an audit opinion.

 

3. In the conduct of our review, 111 branches have been reviewed by either of us which covers 56 percent of the advances portfolio of the bank as at 31st December, 2015. We have also relied upon various returns received from the branches of the bank.

 

4. Based on our review conducted as stated above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the aforesaid Accounting Standards and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, including the manner in which it is to be disclosed, or that it contains any material misstatement or that it has not been prepared in accordance with relevant prudential norms prescribed by the Reserve Bank of India in respect of income recognition, asset classification, provisioning and other related matters.

 

….2

Deloitte

Haskins & Sells

M P Chitale & Co.

 

: 2 :

 

5. Attention is drawn to Note No. 10 of the Statement regarding deferment of shortfall of Rs.7,829.27 Lakhs arising from the sale of certain non-performing assets during the quarter and nine months ended 31st December, 2015 in terms of RBI Master Circular DBR.No.BP.BC.2/21.04.048/2015-16 on Prudential Norms on Income Recognition, Asset Classification and Provisioning pertaining to advances, dated July 1, 2015, and the unamortised balance as at 31st December, 2015 of Rs.6,456.56 Lakhs.

 

Our conclusion is not modified in respect of this matter.

 

 

 

For DELOITTE HASKINS & SELLS

For M P CHITALE & CO.

Chartered Accountants

Chartered Accountants

(Firm's Registration No.008072S)

(Firm's Registration No. 101851W)

 

 

M. Ramachandran

Ashutosh Pednekar

Partner

Partner

(Membership No.16399)

(Membership No. 041037)

 

 

KOCHI, January, 2016.

THE FEDERAL BANK LIMITED

REGD.OFFICE: P.B.NO. 103, FEDERAL TOWERS, ALUVA-683101

(CIN: L65191KL1931PLC000368)

STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED DECEMBER 31, 2015

 (` in Lakhs)

Particulars

Quarter ended

Nine Months ended

Year ended 31.03.2015

31.12.2015

30.09.2015

31.12.2014

31.12.2015

31.12.2014

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Audited

1. Interest earned (a)+(b)+(c)+(d)

190,276

190,226

187,010

571,817

551,118

741,946

(a)

Interest/discount on advances/bills

138,554

140,005

139,896

419,982

406,177

544,683

(b)

Income on Investments

44,589

42,356

40,168

129,982

122,514

164,968

(c)

Interest on balances with Reserve Bank of India and other inter bank funds

1,657

1,905

2,060

4,871

5,638

6,236

(d)

Others

5,476

5,960

4,886

16,982

16,789

26,059

2. Other Income

18,331

18,227

21,991

55,952

57,231

87,831

3. TOTAL INCOME (1+2)

208,607

208,453

209,001

627,769

608,349

829,777

4. Interest expended

129,756

129,392

128,294

389,987

375,400

503,905

5. Operating Expenses (i)+(ii)

46,303

45,404

40,972

134,856

117,085

163,093

(i)

Employees Cost

25,859

24,893

23,507

75,981

64,330

89,196

(ii)

Other operating expenses

20,444

20,511

17,465

58,875

52,755

73,897

6. TOTAL EXPENDITURE (4+5)(excluding Provisions and Contingencies)

176,059

174,796

169,266

524,843

492,485

666,998

7. OPERATING PROFIT (3-6) (Profit before Provisions and Contingencies)

32,548

33,657

39,735

102,926

115,864

162,779

8. Provisions (other than Tax) and Contingencies

7,511

8,728

(82)

31,549

6,697

10,675

9. Exceptional Items

-

-

-

-

-

-

10. Profit from Ordinary Activities before tax(7-8-9)

25,037

24,929

39,817

71,377

109,167

152,104

11. Tax expense

8,765

8,801

13,348

24,838

36,645

51,529

12. Net Profit from Ordinary Activities after tax (10-11)

16,272

16,128

26,469

46,539

72,522

100,575

13. Extraordinary items (net of tax expense)

-

-

-

-

-

-

14. Net Profit for the period (12-13)

16,272

16,128

26,469

46,539

72,522

100,575

15. Paid-up Equity Share Capital (Refer Note 9)(Face value ` 2/- per Equity Share)

34,367

34,349

17,122

34,367

17,122

17,133

16. Reserves excluding Revaluation Reserve

756,180

17. Analytical Ratios

(i)

Percentage of shares held by Government of India

NIL

NIL

NIL

NIL

NIL

NIL

(ii)

Capital Adequacy ratio (%)

Under Basel III

14.32

14.71

14.51

14.32

14.51

15.46

(iii)

Earnings per Share (EPS) (in `) (Refer Note 9)

(a) Basic EPS (before and after Extra ordinary Items)

0.95*

0.94*

1.54*

2.71*

4.23*

5.87

(b) Diluted EPS (before and after Extra ordinary Items)

0.94*

0.92*

1.52*

2.68*

4.15*

5.82

(iv)

NPA Ratios

a) Gross NPA

168,411

149,873

106,663

168,411

106,663

105,773

b) Net NPA

87,610

67,484

33,294

87,610

33,294

37,327

c) % of Gross NPA

3.15

2.90

2.19

3.15

2.19

2.04

d) % of Net NPA

1.66

1.33

0.69

1.66

0.69

0.73

(v)

Return on Assets (%)

 0.19*

0.20*

 0.35*

 0.56*

 0.97*

1.32

*Not Annualised

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTEAXFKFLSKEEF
Date   Source Headline
29th Jun 20151:28 pmRNSResult of Meeting
24th Jun 20157:30 amRNSNotice of Board Meeting
24th Jun 20157:15 amRNSNotice of AGM
3rd Jun 20151:32 pmRNSDividend Declaration
11th May 20158:16 amRNSProposed bonus issue
5th May 201512:47 pmRNSAnnual Financial Report
19th Jan 20151:45 pmRNS3rd Quarter Results
20th Oct 201411:48 amRNSHalf Yearly Report
23rd Jul 201411:29 amRNS1st Quarter Results
23rd Jul 20147:00 amRNSResult of AGM
1st Jul 201411:46 amRNSNotice of AGM
6th May 20141:40 pmRNSAnnual Financial Report
22nd Jan 20148:20 amRNS3rd Quarter Results
21st Oct 20131:16 pmRNSHalf Yearly Report
21st Oct 20139:11 amRNSResult of Meeting
23rd Jul 201310:35 amRNS1st Quarter Results
22nd Jul 201310:26 amRNSResult of AGM
9th Jul 201311:48 amRNSNotice of AGM
9th Jul 201311:31 amRNSAGM Statement
5th Jun 201310:43 amRNSFinal Results
16th Aug 20127:38 amRNS1st Quarter Results
10th Aug 201211:35 amRNSAnnual Information Update
16th Jul 20127:00 amRNSNotice of AGM
29th May 20121:33 pmRNSAnnual Information Update
27th Oct 20117:00 amRNSHalf Yearly Report
26th Aug 20111:30 pmRNS1st Quarter Results
9th May 20117:00 amRNSFinal Results
1st Feb 20119:31 amRNS3rd Quarter Results
1st Nov 201010:39 amRNSHalf Yearly Report
27th Sep 20109:01 amRNSNew MD & CEO and new Director
30th Jul 20109:29 amRNS1st Quarter Results
7th Jul 201010:32 amRNSWhole time Director
17th May 20102:20 pmRNSFinal Results
10th May 20109:35 amRNSRetirement of director
7th Apr 20103:45 pmRNSSecond Price Monitoring Extn
7th Apr 20103:40 pmRNSPrice Monitoring Extension
29th Jan 20107:00 amRNS3rd Quarter Results
2nd Nov 20098:29 amRNSHalf-yearly results
23rd Sep 200910:55 amRNSFinancial Due Diligence
5th Aug 200910:16 amRNS1st Quarter Results
9th Jul 20097:00 amRNSAppointment of director
26th May 20097:00 amRNSFinal Results
16th Jan 200910:04 amRNS3rd Quarter Results
22nd Oct 200812:13 pmRNSInterim Results
4th Aug 20087:00 amRNS1st Quarter Results
27th May 20087:00 amRNSFinancial Results For The Yea
30th Jan 200810:03 amRNS3rd Quarter Results
13th Nov 200712:59 pmRNSFormal Notice
29th Oct 20077:00 amRNSInterim Results
7th Aug 20077:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.